Related Experiment Videos
Limb reduction defects in endothelial nitric oxide synthase-deficient mice
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
The American Journal of Physiology
|December 9, 1998
Summary
Mice lacking endothelial nitric oxide synthase (eNOS) exhibit limb reduction defects and increased neonatal loss. A single functional copy of the Nos3 gene prevents these developmental abnormalities.
Area of Science:
- Developmental Biology
- Genetics
- Molecular Biology
Background:
- Nitric oxide synthases (NOS) produce nitric oxide (NO), a molecule with diverse biological roles.
- Endothelial nitric oxide synthase (eNOS), encoded by Nos3, is crucial for vascular smooth muscle relaxation.
- Previous studies linked NOS inhibition in pregnant rats to limb defects, but eNOS deficiency in mice was unexamined.
Purpose of the Study:
- To investigate the role of eNOS in embryonic development.
- To determine if Nos3 deficiency causes developmental abnormalities, specifically limb reduction defects.
Main Methods:
- Generation of eNOS-deficient (Nos3 null) mice using embryonic stem cell technology.
- Phenotypic analysis of Nos3 null mice for developmental abnormalities.
- Assessment of limb development and neonatal survival rates in deficient and heterozygous mice.
Main Results:
- Approximately 10% of Nos3 null mice displayed limb reduction defects.
- Homozygous deficient pups exhibited increased neonatal mortality.
- Presence of one functional copy of the Nos3 gene (in heterozygous mice) prevented limb defects.
Conclusions:
- eNOS plays a critical role in normal embryonic limb development.
- Nos3 deficiency is associated with significant developmental abnormalities and lethality.
- These findings suggest a potential genetic link between eNOS function and human sporadic limb reduction defects.